JS Link FY 2025 Annual Report
Beta

Filed: March 23, 2026· period ending December 31, 2025DART

JS Link annual report for FY 2025, filed with DART (Korea Financial Supervisory Service) on March 23, 2026. This page provides AI-powered English analysis including business overview, management discussion & analysis (MD&A), risk factors, and KIFRS consolidated financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE).

JS Link FY 2025 Annual Report Analysis

Business Overview

• KRW 19.2B revenue from genome analysis services in FY2025, up from KRW 13.2B in 2024, core business at 99.35% of sales
• Entered permanent sintered magnet production in Aug 2024 targeting EVs, robots, UAM, wind power, defense industries

Management Discussion & Analysis

• Revenue KRW 193.16B (+21.42% YoY), operating loss KRW 12.49B (-37.04%), net loss KRW 16.45B (-52.24%)
• Permanent magnet business initial investment raised operating loss; bio division revenue grew from KRW 13.1B to KRW 19.3B due to customer expansion and demand increase

Risk Factors

• KRW 808B pre-tax income impact from 10% USD exchange rate rise, up from KRW 125B prior year sensitivity
• Derivative assets: KRW 2.13B call options; derivative liabilities: KRW 31M call options as of FY2025

JS Link FY 2025 Key Financial Metrics
DART

Total Assets

KRW 123.0B

▲ +126.2% YoY

Operating Cash Flow

-KRW 9.4B

▼ -38.4% YoY

CapEx

KRW 44.0B

▲ +163.5% YoY

Source: KIFRS consolidated financial data from JS Link annual report on DART. All figures in KRW.

Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding